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Introduction
The monogenic autoinflammatory syndromes are charac-
terised by seemingly unprovoked inflammation which
derives from a disruption of innate immunity. Novel as yet
undefined autosomal recessive syndromes are increasingly
recognised in consanguineous families. This type of family
is ideal for genetic mapping.
Objectives
To conduct genetic mapping and sequencing to identify
the causal variant(s) in a single consanguineous family
with a severe unclassified autoinflammatory disease; and
confirm pathogenicity with functional studies of novel
genetic mutation(s).
Methods
Three affected children in a Pakistani family suffered
from a severe and unusual autoinflammatory syndrome,
presenting in the first year of life with recurrent fevers,
erythema nodosum-like rash, severe oromucocutaneous
ulceration, systemic inflammation, and massively elevated
serum IgD, without mutation in MVK. One of the
affected children also suffered from multifocal sterile
osteomyelitis with bony lytic lesions and died at age 12
months from bronchopneumonia, and acute cervical
myelopathy from cervical vertebral collapse. The two
older children were resistant to treatment with
corticosteroids, colchicine, several different DMARDs,
anakinra and infliximab. Both were cured by allogeneic
haematopoietic stem cell transplantation (HSCT) in their
teenage years and remain well and off all treatment
approximately 5 years later. DNA from the three patients,
two unaffected siblings and their parents were genotyped
on Illumina 610 SNP arrays and this data was used for
homozygosity mapping and parametric multipoint linkage
analysis. A 5Mb region was identified from this mapping.
Candidate genes were chosen by members of an expert
panel and the exons of these genes were Sanger
sequenced. DNA from the entire homozygous region
linked to the disease locus (5Mb) was captured using a
custom designed 385k capture array from Nimblegen and
then resequenced using the Illumina Genome Analyser
II, revealing over 50 coding change variants. These
entered a filtering process involving: the selection of rare
variants and screening of extended family members,
ethnically matched controls from the Jat Kalyal tribe, and
the exclusion of unlikely candidates. siRNA knockdown
was conducted in THP1 monocytic cells derived to
macrophages with measurement of cytokine and reactive
oxygen species (ROS) production measured by flow
cytometry and electron spin resonance (ESR).
Results
A missense variant of interest in a mitochondrial cha-
perone-like protein was discovered that fully segregated
with disease in the family. Knockdown of this protein in1UCL Institute of Child Health, London, UK
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THP1-derived macrophages caused an enhanced pro-
duction of mitochondrial superoxide detectable by ESR
and mitoSOX fluorescence, and increased production of
TNF-alpha.
Conclusion
We describe a novel monogenic autoinflammatory disease
driven by mitochondrial ROS production, leading to
enhanced inflammatory responses. Increased leucocyte
ROS have previously been implicated in other autoinflam-
matory diseases (TRAPS, FMF, CAPS and FCAS2); we
suggest that this was the cause of the severe, recalcitrant
and novel autoinflammatory syndrome in the family
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